BAN2401Demonstrates Statistically Significant Clinical Data for 18 Months Study
We will review our numbers and rating after review of the full data at AAIC and for now maintain our “Equal-weight” rating on the...
409 Views
Merck Alliance Provides Stability to Deal With the Outcome of High Risk Alzheimer’s R&D in FY19
We upgrade Eisai Co Ltd (4523 JP) to “Equal-weight” after reviewing our model post FY17 (YE Mar-18) earnings, in light of the augmented peak sales...
255 Views
Japan: Sectors/Peer Groups 3M🔺Too Early to Bottom-Fish Cyclicals •Time to Trim Personal Products
THREE-MONTH % CHANGE IN SECTORS & PEER GROUPS - This regular insight focuses on the percentage change in each sectors' weight in the market...
136 Views
Eisai FY17 Earnings - First Glance
Eisai Co Ltd (4523 JP) reported FY17 results on May 15, 2018 Lenvima sales ramp-up + Upfront payment from Merck led FY17 topline growth and gross...
98 Views
Japan Pharmaceuticals: FY17e Earnings Preview (II)
Shionogi & Co Ltd (4507 JP) - May 09, 2018FY18e Potential GuidanceHIV franchise continues its growth trajectory, however, genericization of its...
115 Views